Sharon Dror, Sandberg Michael A, Caruso Rafael C, Berson Eliot L, Dryja Thaddeus P
Ocular Molecular Genetics Institute and the Berman-Gund Laboratory for the Study of Retinal Degenerations, Harvard Medical School, Massachusetts Eye and Ear Infirmary, Boston 02114, USA.
Arch Ophthalmol. 2003 Sep;121(9):1316-23. doi: 10.1001/archopht.121.9.1316.
To determine if enhanced s-cone syndrome (ESCS), Goldmann-Favre syndrome (GFS), and clumped pigmentary retinal degeneration (CPRD) are caused by mutations in the NR2E3 gene and to characterize the clinical findings in patients with NR2E3 mutations. Patients One patient with ESCS, one with GFS, and 20 with CPRD.
The coding regions of the NR2E3 and NRL genes and part of the THRB1 coding region were scanned for mutations using single-strand conformation and direct sequencing methods. We evaluated visual acuity, refractive error, visual fields, fundi, final dark-adaptation thresholds, and electroretinograms (ERGs).
The patients with ESCS and GFS and 9 of the 20 unrelated patients with CPRD had mutations in the NR2E3 gene. Six mutations were found in these 11 patients, including 2 novel mutations: the missense mutation Ala256Glu and the frameshift mutation Pro276del17 (the first obviously null allele reported). Three patients were mutant homozygotes, and 8 had 2 mutations. All but one of the mutations in the patients with ESCS and GFS were also found in patients with CPRD. All NR2E3 cases were hyperopes and had retinal vascular attenuation and reduced and delayed full-field ERGs. Clumped pigment deposits were recognized in the patients with ESCS and GFS. The CPRD patients without NR2E3 mutations had no detected mutations in NRL or THRB1.
We found that ESCS, GFS, and CPRD can all have the same genetic basis. Clinical Relevance The combination of night blindness, hyperopia, and clumped retinal pigment deposits should raise the suspicion that a patient has NR2E3 disease.
确定增强型视锥细胞综合征(ESCS)、戈德曼 - 法夫尔综合征(GFS)和聚集性色素性视网膜变性(CPRD)是否由NR2E3基因突变引起,并描述携带NR2E3基因突变患者的临床特征。患者 1 例 ESCS 患者、1 例 GFS 患者和 20 例 CPRD 患者。
采用单链构象和直接测序方法扫描 NR2E3 和 NRL 基因的编码区以及 THRB1 编码区的一部分,以寻找突变。我们评估了视力、屈光不正、视野、眼底、最终暗适应阈值和视网膜电图(ERG)。
ESCS 和 GFS 患者以及 20 例不相关的 CPRD 患者中的 9 例有 NR2E3 基因突变。在这 11 名患者中发现了 6 种突变,包括 2 种新突变:错义突变 Ala256Glu 和移码突变 Pro276del17(报道的第一个明显的无效等位基因)。3 例患者为突变纯合子,8 例有 2 种突变。ESCS 和 GFS 患者中除 1 种突变外,其余所有突变在 CPRD 患者中也有发现。所有 NR2E3 病例均为远视,有视网膜血管变细,全视野 ERG 降低和延迟。在 ESCS 和 GFS 患者中发现有聚集性色素沉着。没有 NR2E3 基因突变的 CPRD 患者在 NRL 或 THRB1 中未检测到突变。
我们发现 ESCS、GFS 和 CPRD 都可能有相同的遗传基础。临床意义 夜盲、远视和视网膜色素聚集的组合应引起怀疑患者患有 NR2E3 疾病。